New technique treats prostate cancer in just five radiotherapy sessions
A new clinical trial proves the benefits of an innovative form of radiotherapy that reduces the treatment to five sessions instead of the usual 37.
Fighting prostate cancer with groundbreaking new technique
Creating a way to keep prostate cancer cells alive in the laboratory for longer leads to quicker drug trials. Sharing this widely speeds it up further.
What makes prostate cancer become aggressive? Study investigates
Using a range of tools, researchers identify a plausible mechanism and genes through which a genetic variation influences prostate cancer aggressiveness.
Prostate cancer: New drug for aggressive, resistant cases
Enzalutamide reduced metastasis or death risk by 71 percent in phase III trial of castration-resistant nonmetastatic prostate cancer with escalating PSA.
Prostate cancer: Scientists find 63 'new genetic markers'
Research locates new genetic markers that may show an elevated risk of developing prostate cancer. This will help to identify men who need early screening.
Immunotherapy effective against 'untreatable' prostate cancer
For the first time, a major clinical trial shows that immunotherapy can successfully treat very advanced forms of prostate cancer.
Targeting this gene could kill prostate cancer
Could a long noncoding RNA that has a role in androgen receptor signaling in prostate cancer be a treatment target that does not lead to resistance?
Can women get prostate cancer?
Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.
Experimental drug targets prostate cancer's chief weakness
In prostate cancer, recurring tumors become aggressive and treatment-resistant. Why does this happen, and how can it be prevented? A new study weighs in.
Prostate cancer: Big data unlocks 80 new drug targets
In the largest study of its type, researchers find several new prostate cancer drug targets by harvesting and analyzing reams of genetic data.